TITLE

Giant Cystadenoma of Prostate

AUTHOR(S)
Thomas, Ajit J.; Mistry, Yogesh; Gopalakrishnan, Ganesh
PUB. DATE
January 2009
SOURCE
Urology Journal;Jan2009, Vol. 6 Issue 1, p57
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a case study of a man suffering from giant prostate cystadenoma with recurrent growth due to incomplete tumor resection. The man presented to a medical college in May 2007 with a mass in his lower abdomen. Immunohistochemistry examination revealed lining epithelium showing strong immunostaining for monoclonal prostate-specific antigen.
ACCESSION #
40085340

 

Related Articles

  • NSAIDs may lower PSA levels.  // Hem/Onc Today;12/10/2008, Vol. 9 Issue 22, p27 

    The article focuses on a study which found that taking aspirin and other non-steroidal anti-inflammatory drugs (NSAID) may lower prostate specific antigen (PSA) levels especially in men with prostate cancer. Study participants included men aged 40 years or older who had been scheduled for...

  • High PSA Not Always a Negative Outcome Predictor.  // Renal & Urology News;Aug2010, Vol. 9 Issue 8, p10 

    The article reports that prostate cancer patients who have high prostate-specific antigen (PSA) levels are not always a negative outcome predictor.

  • Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report. Hingorani, Rittu; Young, Jessica; Alweis, Richard // Journal of Community Hospital Internal Medicine Perspectives (JC;2014, Vol. 4 Issue 5, p1 

    Background: Neuroendocrine prostate cancer is rare but lethal. It is one of the most common extra pulmonary manifestations of small cell cancer. Case presentation: Here we present a case report of a 53-year-old male who presents with a mixed adenocarcinoma and neuroendocrine prostate tumor on a...

  • Charlson Comorbidity Index Is an Important Prognostic Factor for Long-Term Survival Outcomes in Korean Men with Prostate Cancer after Radical Prostatectomy. Joo Yong Lee; Dae Hun Lee; Nam Hoon Cho; Koon Ho Rha; Young Deuk Choi; Sung Joon Hong; Seung Choul Yang; Kang Su Cho // Yonsei Medical Journal;Mar2014, Vol. 55 Issue 2, p316 

    Purpose: To analyze overall survival (OS), prostate cancer (PCa)-specific survival (PCaSS), and non-PCaSS according to the Charlson Comorbidity Index (CCI) after radical prostatectomy (RP) for PCa. Materials and Methods: Data from 336 patients who had RP for PCa between 1992 and 2005 were...

  • Pomegranate juice extract may increase PSA doubling time. Volansky, Rob // Hem/Onc Today;3/10/2011, Vol. 12 Issue 5, p18 

    The article discusses a research study, led by Doctor Michael A. Carducci, which found that pomegranate juice extract may increase prostate-specific antigen (PSA) doubling time in non-metastatic patients with prostate cancer.

  • PSADT Predicts Post RP Death.  // Renal & Urology News;Apr2010, Vol. 9 Issue 4, p20 

    The article presents a study, conducted by Emmanuel S. Antonarakis of Johns Hopkins University in Baltimore, Maryland, which shows that prostate-specific antigen doubling time (PSADT) is the most significant predictor of 15-year overall survival in men experiencing biochemical recurrence after...

  • Denosumab Delays Bone Metastases.  // Renal & Urology News;Aug2013, Vol. 12 Issue 8, p7 

    The article reports on a study by doctor Blair Egerdie and colleagues which revealed that denosumab delays the median time to the development of bone metastases in men, who have prostate-specific antigen (PSA) doubling time (PSADT) and non-metastatic castrate-resistant prostate cancer (CRPC).

  • Tumor Size Predicts Biochemical Recurrence Risk.  // Renal & Urology News;Jul2014, Vol. 13 Issue 7, p25 

    The article offers information on a study which discusses the use of maximal tumor diameter (MTD) to predict risk of prostate-specific antigen (PSA) failure among patients.

  • Palpable Tumors Plus Low PSA May Increase PCSM. CHARNOW, JODY A. // Renal & Urology News;Oct2014, Vol. 13 Issue 10, p11 

    The article reports that palpable prostate cancer (PCa) with low prostate-specific antigen (PSA) increase the risk of cancer-related death.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics